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In This IssueIn Review: Microtubules and the Drug Binding Sites
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Microtubules (MTs) are a highly successful target for anticancer therapy. There are three possible binding sites for
compounds to bind and stabilize the MT; however, controversy surrounds their exact location and nature. Field et al. review
current understanding of the sites and their proposed interactions.CIn Review: Prohibitins in Sickness and in
Health
PAGE 316
Prohibitins are scaffold proteins that modulate many signaling pathways
controlling cell survival, metabolism, and inflammation. Thuaud et al.
review prohibitins in health and diseases, current developments of small
molecules targeting prohibitins, and their therapeutic potential.From Yeast Assay to Human Telomerase
PAGE 333
Ability of baker’s yeast to arrest cell division reversibly in response
to the expression of human telomerase was used to screen forcompounds that impaired the enzyme. Wong et al. found several compounds with desired activity, establishing yeast as
a model system to identify new probes for telomerase function.Regulation of Telomere Length
PAGE 341
G-quadruplex structures are formed by mammalian telomere DNA and telomeric repeat containing RNA (TERRA), but with
what purpose? Takahama et al. show that G-quadruplexes function as scaffolds for a telomere binding protein TLS/FUS
and thus regulate histone modifications and telomere length.Peptoid Ligands for Anti-Aquaporin 4Antibodies
PAGE 351
In neuromyelitis optica (NMO) patients, autoantibodies to the water channel
protein Aquaporin 4 (AQP4) are present at high levels and might lead to
pathology. Raveendra et al. apply chemical library screening technology to
identify synthetic peptoids that bind to anti-AQP4 antibodies in the serum of
NMO patients.Library for Conformationally Restrained
Peptide Tertiary Amides
PAGE 360
Finding a way to constrain peptoids or peptides is of interest given that it might
improve their biological activity. Gao and Kodadek apply creative chemistry to
generate libraries of peptide tertiary amides (PTAs), N-alkylated alanines, and
demonstrate their higher affinity for protein targets.Bayesian Models for Drug Discovery
PAGE 370
Lead generation represents a challenge in the resource-limited setting of drug discovery. Ekins et al. use public HTS data to
construct Bayesianmachine learningmodels ofMtb activity and cytotoxicity. Themodels offer improvements in time and cost
and result in potent hits with the safety profile of a drug lead.hemistry & Biology 20, March 21, 2013 ª2013 Elsevier Ltd All rights reserved v
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In This IssueUltrapotent and Selective Inhibitors of Monoacylglycerol Lipase
PAGE 379
Monoacylglycerol lipase (MAGL) might be a relevant drug target for treatments of neurodegenerative diseases and cancer.
Aaltonen et al. design and characterize piperazine and piperidine triazole ureas as highly potent and MAGL-selective inhib-
itors, culminating in the compound JJKK-048, which has remarkable potency.Oxysterol-Derived Pharmacological Chaperones for NPC1
PAGE 391
NPC1 is an endosomal membrane protein essential for cholesterol transport, and the loss of function leads to Niemann-Pick
disease type C. Ohgane et al. discover that oxysterol derivatives act as pharmacological chaperones and rescue folding-
defective phenotypes through a novel sterol-binding site on NPC1.vi Chemistry & Biology 20, March 21, 2013 ª201Getting to the Gaucher’s Disease
PAGE 403
Lysosomal storage diseases are often caused by mutations in the lysosomal
enzymes that lead to excessive misfolding and degradation of the mutant
enzymes and loss of function. Ong et al. show that targeting FKBP10 appears
to be a heretofore unrecognized therapeutic strategy to ameliorate misfolding
diseases.All Out Synthetic Nucleotides
PAGE 416
Jang et al. describe fully modified nucleotides with altered base, sugar, and
leaving group that function as substrate for the DNA polymerases. This brings
us a step closer to synthetic genetic material that is built out of artificial nucleic
acids and able to carry orthogonal hereditary information in vivo.Viruses Everywhere: Beware!
PAGE 424
Although critically needed, there are no effective small-molecule therapies for most viruses, including highly pathogenic ones
such as Ebola. Filone et al. identify indoline alkaloid-like compounds that inhibit the replication of genetically diverse viruses,
including Ebola, by limiting RNA production.Imaging Single-Copy Genomic DNA
PAGE 445
Yaroslavsky and Smolina report a method for fluorescent in situ detection of
short, single-copy sequences within human genomic DNA. The method
combines the use of PNA probes to locally open dsDNAwith rolling circle ampli-
fication to generate thousands of copies of the target sequence, visualized by
fluorescence.Multivalency Orchestrates Delivery
PAGE 434
McNaughton et al. identify a protein transduction domain that selectively
penetrates a prostate cancer cell line. They show that both the potency and
selectivity of cell uptake is dependent upon multivalency effects, revealing
a protein transduction domain with tunable cell-penetrating potency and
selectivity.3 Elsevier Ltd All rights reserved
